Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
50%(5 trials)

Phase Distribution

Ph phase_1
3
30%
Ph phase_2
2
20%
Ph phase_3
5
50%

Phase Distribution

3

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
5(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (30.0%)
Phase 22 (20.0%)
Phase 35 (50.0%)

Trials by Status

completed10100%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_3

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

NCT01532414
completedphase_1

An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration

NCT02274181
completedphase_1

A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal

NCT01959685
completedphase_1

Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males

NCT01991327
completedphase_2

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

NCT01270841
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT01532414Phase 3

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Completed
NCT02274181Phase 1

An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration

Completed
NCT01959685Phase 1

A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal

Completed
NCT01991327Phase 1

Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males

Completed
NCT01270841Phase 2

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

Completed
NCT01191320Phase 2

Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

Completed
NCT01534208Phase 3

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Completed
NCT01067365Phase 3

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

Completed
NCT01739582Phase 3

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Completed
NCT00962637Phase 3

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10